Dravet's

Biotech stocks present an exciting investment opportunity, given the heady gains they can fetch if one places the right bet at the right time. The IPO Terms Stoke Therapeutics, Inc. this week proposes to offer 6.7 million shares at an estimated price range of $14-$16, according to an amended S-1...